Zolbetuximab: A Narrative Drug Review
Claudin-18.2 (CLDN18.2) is a tight junction protein selectively expressed in a subset of gastric and gastroesophageal junction (GEJ) adenocarcinomas, making it a promising therapeutic target. Zolbetuximab is a first-in-class chimeric IgG1 monoclonal antibody that binds to CLDN18.2-positive tumor cel...
Na minha lista:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
|
| Serier: | Indian Journal of Medical and Paediatric Oncology |
| Fag: | |
| Online adgang: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0046-1816546 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|